Studies relating to the development of a galenical drug with antimicrobial activity from clove buds


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the results of studies on the development of a galenical drug with antimicrobial activity from clove buds. For studies, we used grinded clove buds with particles fraction less than 0.5 mm. As an extractant, we used ethanol with different concentration 26, 43, 56, 72, 82, 97±1% v/v. Methods of extraction: simple maceration and filtration extraction. Methods of analyses: RP HPLC and gravimetry. Standard substances were eugenol and gallic acid. Analytical wave lengths were 370, 282, and 270 nm. For the antibacterial study of extracts, we used the agar well diffusion method. In our research, we used six test-strain microorganisms: Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Proteus vulgaris ATCC 4636, Pseudomonas aeruginosa ATCC 27853, Candida albicans ATCC 885/653, and Bacillus subtilis ATCC 6633. Ethanol concentration, which extracts most of the substances was found; minimal eugenol concentration in the extract and tincture for their standardizations was suggested; the level of antimicrobial activity of ethanol-water extracts equivalent to a reference drug was determined. It was found that the major yield among the substances determined is observed with an ethanol concentration of 80±5% v/v. It was found that using filtration extraction method for one hour of the extraction process, we could obtain the liquid extract 1:1 m/v with eugenol concentration of 13.8% m/v and its yield 93%. In two and a half hours of the extraction process, we could obtain the tincture 1:5 m/v with eugenol concentration of 3.0% m/v and its yield 100%. RP HPLC method of analysis determined the presence of the following nine main substances: eugenol, acetyl eugenol, gallic acid, three flavonoids, and three non-identified substances in ethanol-water extracts from clove buds. It was suggested to carry out standardization of the resulting galenical drugs by eugenol. For the extract (1:1 m/v), low limit of eugenol concentration 13.0% m/v was suggested, and for the tincture (1:10 m/v), low limit of eugenol concentration 1.3% m/v was suggested. Antimicrobial activity of ethanol-water solutions of the extract (1:1 m/v) was studied; the lowest eugenol concentration of 0.44% m/v in ethanol-water solutions equivalent in terms of its antimicrobial activity to the reference drug 0.05% chlorhexidine digluconate water solution.

Full Text

Restricted Access

About the authors

N. N Boyko

Belgorod National Research University

Email: boykoniknik@gmail.com
Ph.D. (Pharm.), Junior Research Scientist of Laboratory Technology of Drugs, Associate Professor of Pharmaceutical Technology Department Belgorod, Russia

D. I Pisarev

Belgorod National Research University

Dr.Sc. (Pharm.), Professor of General Chemistry Department Belgorod, Russia

E. T Zhilyakova

Belgorod National Research University

Dr.Sc. (Pharm.), Professor, Head of Pharmaceutical Technology Department Belgorod, Russia

A. Yu Maljutina

Belgorod National Research University

Ph.D. (Pharm.), Associate Professor of General Chemistry Department Belgorod, Russia

O. O Novikov

«Drugs Quality Control Center»; Рeoples' Friendship University of Russia

Director of Shared Knowledge Center (Research and Educational Center) Moscow, Russia

T. P Osolodchenko

Mechnikov Institute of Microbiology and Immunology of the National Academy of Medical Sciences of Ukraine

Ph.D. (Biol.), Senior Research Scientist, Head of Laboratory of Biochemistry and Biotechnology Kharkov, Ukraina

M. S Ghazaryan

Yerevan State University

Magister of Institute of Pharmacy Yerevan, Armenia

References

  1. Микляев С.В., Леонова О.М., Сущенко А.В. Анализ распространенности хронических воспалительных заболеваний тканей пародонта // Современные проблемы науки и образования. 2018(2); URL: http://www.science-education.ru/ru/article/view?id=27454 (дата обращения: 09.07.2019).
  2. Лукичев М.М., Ермолаева Л.А. Современные представления о роли микрофлоры в патогенезе заболеваний пародонта // Институт Стоматологии. 2018; 1(78):92-94.
  3. Wilder R.S., Ryan M.E. Chemotherapeutics in the treatment of periodontal disease // Decisions in Dentistry. 2018; 4(4):49-52.
  4. Haque M., Sartelli M., Haque S.Z. Dental Infection and Resistance-Global Health Consequences. // Dent J (Basel). 2019; 7(1):22.
  5. Ishnava K.B. Role of herbal medicine in dental health // J Environ Chem Toxicol. 2018; 2(1):28-29.
  6. Saquib S.A., AlQahtani N.A., Ahmad I., Kader M.A., Al Shahrani S.S., Asiri E.A. Evaluation and comparison of antibacterial efficacy of herbal extracts in combination with antibiotics on periodontal pathobionts: an in vitro microbiological study // Antibiotics (Basel). 2019; 8(3):89-101.
  7. Cheesman M.J., Ilanko A., Blonk B., Cock I.E. Developing new antimicrobial therapies: are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution? // Phcog Rev. 2017; 11:57-72.
  8. Marchese A., Barbieri R., Coppo E., Orhan I.E., Daglia M., Nabavi S.F., Izadi M., Abdollahi M., Nabavi S.M., Ajami M. Antimicrobial activity of eugenol and essential oils containing eugenol: a mechanistic viewpoint // Critical Reviews in Microbiology. 2017; 43(6):668-689.
  9. Thosar N.R., Chandak M., Bhat M., Basak S. Evaluation of antimicrobial activity of two endodontic sealers: zinc oxide with thyme oil and zinc oxide eugenol against root canal microorganisms -an in vitro study // International journal of clinical pediatric dentistry. 2018; 11(2), 79-82.
  10. Markowitz K., Moynihan M., Liu M., Kim S. Biologic properties of eugenol and zinc oxide-eugenol // Oral surgery, oral medicicne, oral pathology, oral radiology. 1992; 73(6):729-737.
  11. Попова Н.В., Литвиненко В.И., Куцанян А.С. Лекарственные растения мировой флоры: энциклопед. Справочник. Харьков: Діса плюс, 2016. 540 с.
  12. Mittal M., Gupta N., Parashar P., Mehra V., Khatri M. Phytochemical evaluation and pharmacological activity of Syzygium aromaticum: a comprehensive review // Int J Pharm Pharm Sci. 2014; 6(8):67-72.
  13. Lim T.K. Edible Medicinal and Non Medicinal Plants: Volume 8, Flowers. Springer Netherlands, 2014; P.460-482.
  14. Zhilyakova E.T., Novikov O.O., Pisarev D.I., Malyutina A.Y., Boyko N.N. Studying the polyphenolic structure of Laurus Nobilis L. leaves // Indo Am J Pharm Sc. 2017;4(09):3066-3074.
  15. Государственная фармакопея Российской Федерации. XIV издание. Том I. Москва: Министерство здравоохранения Российской Федерации, 2018.
  16. European Pharmacopoeia. 8th ed. Strasbourg: European Directorate for the Quality of Medicines & HealthCare, 2014.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies